Variations in time of market exclusivity among top-selling prescription drugs in the United States

JAMA Intern Med. 2015 Apr;175(4):635-7. doi: 10.1001/jamainternmed.2014.7968.

Authors

Bo Wang¹, Jun Liu¹, Aaron S Kesselheim¹

Affiliation

¹ The Program On Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

PMID: 25664700
DOI: 10.1001/jamainternmed.2014.7968

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Drug Approval
Drug Industry* / economics
Drugs, Generic / economics
Economic Competition*
Health Care Sector* / economics
Humans
Patents as Topic*
Prescription Drugs*
Time Factors
United States
United States Food and Drug Administration

Substances

Drugs, Generic
Prescription Drugs